Waiv, a Paris, France–based company catalyzing AI precision testing, has raised $33 million in financing.
Investors
The round was co-led by OTB Ventures and Alpha Intelligence Capital, with participation from Serena Data Ventures, Karista, and SistaFund.
OTB Ventures is a pan-European deep-tech VC fund specializing in Series A and late-seed rounds. Its focus is on supporting startups that pioneer unique technologies across three key verticals: AI and novel computing, SpaceTech, and robotics and physical AI. Established in 2017, OTB Ventures currently manages approximately €350 million and has offices in Warsaw, Luxembourg, and Amsterdam.
Alpha Intelligence Capital (AIC) is a global venture capital firm fully dedicated to artificial intelligence. Founded in 2018, AIC invests globally in companies developing advanced AI technologies. The firm is based in San Francisco, Paris, and Singapore, and manages over $450 million across two funds. AIC’s family of funds holds or has held equity stakes in more than 50 companies across multiple stages and sectors, including healthcare, compute infrastructure, and cybersecurity. Its portfolio spans the United States, Europe, Israel, Australia, the United Arab Emirates, and Singapore.
Waiv Use of Funds
The company will use the funding to expand its portfolio of clinical-grade multimodal tests, strengthen pharmaceutical partnerships across R&D pipelines, and expand international market access.
About Waiv
Founded by Meriem Sefta and Lionel Guillou, Waiv is a healthcare technology company developing AI-native precision testing solutions for oncology. Its platform transforms digital histopathology images and multimodal clinical data into clinically validated precision tests. The company’s AI stack combines proprietary foundation models, multimodal analytics, and clinical validation to deliver scalable diagnostic insights for laboratories, clinicians, and pharmaceutical partners. Spun out from Owkin, its technology is already used in solutions such as RlapsRisk BC, MSIntuit Suite, and BRCAura.
Funding Details
Company: Waiv
Raised: $33.0M
Round: Unknown
Funding Date: March 2026
Lead Investor: OTB Ventures, Alpha Intelligence Capital
Additional Investors: Serena Data Ventures, Karista, SistaFund
Company Website: https://wearewaiv.com/
Software Category: AI Precision Oncology Testing Platform
Source: https://wearewaiv.com/news/waiv-secures-33-million-to-scale-ai-precision-testing